Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Emory University
Replimune Inc.
M.D. Anderson Cancer Center
Novelty Nobility, Inc.
Turnstone Biologics, Corp.
National Cancer Institute (NCI)
Provectus Pharmaceuticals
Opna Bio LLC
Pfizer
Incyte Corporation
Yale University
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)